Not only ACE2-the quest for additional host cell mediators of SARS-CoV-2 infection: Neuropilin-1 (NRP1) as a novel SARS-CoV-2 host cell entry mediator implicated in COVID-19.

Kyrou, Ioannis; Randeva, Harpal S; Spandidos, Demetrios A; Karteris, Emmanouil

Kyrou, Ioannis; Randeva, Harpal S; Spandidos, Demetrios A; Karteris, Emmanouil.

Kyrou I; Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism (WISDEM), University Hospitals Coventry and Warwickshire NHS Trust, Coventry, CV2 2DX, UK. i.kyrou@aston.ac.uk.
Randeva HS; Aston Medical Research Institute, Aston Medical School, College of Health and Life Sciences, Aston University, Birmingham, B4 7ET, UK. i.kyrou@aston.ac.uk.
Spandidos DA; Warwick Medical School, University of Warwick, Coventry, CV4 7AL, UK. i.kyrou@aston.ac.uk.
Karteris E; Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism (WISDEM), University Hospitals Coventry and Warwickshire NHS Trust, Coventry, CV2 2DX, UK.

Signal Transduct Target Ther ; 6(1): 21, 2021 01 18.

Article in English | MEDLINE | ID: covidwho-1065843

Subject(s)

COVID-19; Peptidyl-Dipeptidase A; Humans; Neuropilin-1/genetics; Peptidyl-Dipeptidase A/genetics; SARS-CoV-2; Virus Internalization

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Peptidyl-Dipeptidase A / COVID-19 Limits: Humans Language: English Journal: Signal Transduct Target Ther Year: 2021 Document Type: Article Affiliation country: S41392-020-00460-9

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google